Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Scancell Holdings (SCLP) Share Price

Price 11.75p on 14-01-2026 at 09:55:26
Change 0.00p 0%
Buy 12.00p
Sell 11.50p
Last Trade: Sell 12,557.00 at 11.70p
Day's Volume: 101,016
Last Close: 11.75p
Open: 11.75p
ISIN: GB00B63D3314
Day's Range 11.75p - 11.75p
52wk Range: 7.25p - 12.25p
Market Capitalisation: £121.94m
VWAP: 11.7409p
Shares in Issue: 1.04b

Scancell Holdings (SCLP) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 12,557 11.70p Ordinary
09:55:25 - 14-Jan-26
Sell* 45,000 11.70p Ordinary
09:54:44 - 14-Jan-26
Sell* 18,823 11.70p Ordinary
09:29:11 - 14-Jan-26
Buy* 166 11.89p Ordinary
08:53:33 - 14-Jan-26
Buy* 20,000 11.89p Ordinary
08:11:09 - 14-Jan-26
Sell* 3,470 11.70p Ordinary
08:04:45 - 14-Jan-26
Buy* 1,000 12.00p Ordinary
08:00:19 - 14-Jan-26
Unknown* 120,000 11.75p OTC Trade
17:07:17 - 13-Jan-26
Sell* 8,650 11.70p Ordinary
16:15:24 - 13-Jan-26
Buy* 10,900 11.94p Ordinary
15:54:38 - 13-Jan-26
See more Scancell Holdings trades

Scancell Holdings (SCLP) Share Price History

Time period:
to
Date Open High Low Close Volume
14th Jan 2026 (Wed) 11.75 11.75 11.75 11.75 101,016
13th Jan 2026 (Tue) 12.25 12.25 11.75 11.75 2,518,014
12th Jan 2026 (Mon) 11.25 12.25 11.75 12.25 3,539,873
9th Jan 2026 (Fri) 10.90 11.25 10.75 11.25 3,062,664
8th Jan 2026 (Thu) 10.00 10.75 10.00 10.75 1,761,982
7th Jan 2026 (Wed) 10.00 10.00 10.00 10.00 486,049
6th Jan 2026 (Tue) 10.10 10.10 9.90 10.00 4,772,136
5th Jan 2026 (Mon) 9.90 10.10 9.90 10.10 2,675,181
2nd Jan 2026 (Fri) 9.90 9.90 9.90 9.90 80,893
1st Jan 2026 (Thu) 9.90 9.90 9.90 9.90 0
31st Dec 2025 (Wed) 9.90 9.90 9.90 9.90 302,135
30th Dec 2025 (Tue) 9.75 9.90 9.75 9.90 619,718
29th Dec 2025 (Mon) 9.75 9.75 9.75 9.75 106,694
26th Dec 2025 (Fri) 9.75 9.75 9.75 9.75 0
25th Dec 2025 (Thu) 9.75 9.75 9.75 9.75 0
24th Dec 2025 (Wed) 9.75 9.75 9.75 9.75 157,764
23rd Dec 2025 (Tue) 9.80 9.85 9.75 9.75 249,610
22nd Dec 2025 (Mon) 10.00 9.90 9.90 9.90 4,184,605
19th Dec 2025 (Fri) 10.20 10.20 10.00 10.00 524,685
18th Dec 2025 (Thu) 10.20 10.20 10.20 10.20 412,313
17th Dec 2025 (Wed) 10.20 10.20 10.20 10.20 646,362
16th Dec 2025 (Tue) 10.20 10.20 10.20 10.20 641,911
15th Dec 2025 (Mon) 9.95 10.20 9.95 10.20 2,179,129
See more Scancell Holdings price history

Scancell Holdings (SCLP) Regulatory News

Date Source Headline
9th Dec 2025 7:00 am RNS Continued improvement in PFS with iSCIB1+
7th Nov 2025 7:00 am RNS Research Update
30th Oct 2025 3:30 pm RNS Result of AGM
3rd Oct 2025 7:00 am RNS Notice of AGM
16th Sep 2025 7:00 am RNS Director Dealing
11th Sep 2025 7:00 am RNS Final Results
4th Sep 2025 7:00 am RNS Notice of Results
8th Aug 2025 12:31 pm RNS Director Dealing
4th Aug 2025 10:23 am RNS Director/PDMR Shareholding
22nd Jul 2025 7:00 am RNS Strong Phase 2 data on iSCIB1+ in Melanoma
See more Scancell Holdings regulatory news

Scancell Holdings (SCLP) Share News

UK shareholder meetings calendar - next 7 days

23rd Oct 2025 14:28

Read More

TRADING UPDATES: Gfinity's Yentra partners with ESG Institute

17th Sep 2025 06:55

(Alliance News) - The following is a round-up of trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

Scancell Holdings notes "tough" macro-environment as loss widens

11th Sep 2025 12:06

(Alliance News) - Scancell Holdings PLC on Thursday said it has made "strong progress" over the last 18 months, but noted impacts from the "tough macroeconomic environment", as it posted a wider full-year loss. Read More

TRADING UPDATES: Scancell reports positive data from melanoma trial

23rd Jul 2025 16:47

(Alliance News) - The following is a round-up of updates and earnings by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

Scancell partners with NHS to fast-track melanoma vaccine trial

14th Apr 2025 14:02

(Alliance News) - Scancell Holdings PLC on Monday said it has partnered with the NHS Cancer Vaccine Launch Pad, to accelerate patient recruitment into the fourth cohort of its phase 2 scope study for a targeted melanoma vaccine. Read More

See more Scancell Holdings news
FTSE 100 Latest
Value10,164.33
Change26.98

Login to your account

Forgot Password?

Not Registered